News

Deal Announcements

Sequenta Secures Third Venture Capital Investment

Wednesday, July 3, 2013 5:56:00 AM PDT | VentureDeal
   South San Francisco, California  --  Biotechnology company Sequenta has raised $20 million in its Series C round of institutional venture capital funding.

Sequenta is developing clinical diagnostics based on what it calls a "revolutionary new platform for understanding immune system status."

Foresite Capital, Mohr Davidow Ventures and Index Ventures made the investment.

The company said it would use the funding proceeds to scale up and validate its ClonoSIGHT test.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1